Compare HALO & AMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | AMH |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 12.0B |
| IPO Year | 2001 | 2012 |
| Metric | HALO | AMH |
|---|---|---|
| Price | $100.98 | $32.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 24 |
| Target Price | ★ $119.89 | $36.66 |
| AVG Volume (30 Days) | 2.3M | ★ 2.4M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 4.06% |
| EPS Growth | N/A | ★ 9.26 |
| EPS | ★ 5.12 | 0.89 |
| Revenue | $151,862,000.00 | ★ $1,182,836,000.00 |
| Revenue This Year | $35.97 | $3.16 |
| Revenue Next Year | $14.85 | $3.46 |
| P/E Ratio | ★ $19.84 | $36.55 |
| Revenue Growth | N/A | ★ 3.45 |
| 52 Week Low | $61.23 | $27.22 |
| 52 Week High | $134.00 | $35.07 |
| Indicator | HALO | AMH |
|---|---|---|
| Relative Strength Index (RSI) | 27.51 | 56.17 |
| Support Level | $64.08 | $31.63 |
| Resistance Level | $111.15 | $32.47 |
| Average True Range (ATR) | 4.64 | 0.60 |
| MACD | -3.78 | 0.08 |
| Stochastic Oscillator | 6.04 | 54.09 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.